This inventor holds 2 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 1998-2000.
Location History:
- Oslo, DK (1998)
- Voyenenga, NO (2000)
Company Filing History:
Years Active: 1998-2000
Title: Innovations of Henrik Fredholm
Introduction
Henrik Fredholm is a notable inventor based in Voyenenga, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of cellulase variants. With a total of 2 patents, his work has implications in various industries, including detergents and textile treatment.
Latest Patents
One of Henrik's latest patents focuses on cellulase variants. This invention provides variants of a parent cellulase, such as a cellulase classified in family 45, specifically a Humicola insolens 43 kD endoglucanase. The invention includes a cellulose binding domain (CBD), a catalytically active domain (CAD), and a linking region. Modifications to the amino acid residues of these domains enhance properties such as alkaline activity and compatibility with detergent ingredients. These variants are particularly useful in applications like textile treatment, paper pulp processing, and stone-washing of jeans.
Career Highlights
Henrik Fredholm is associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to focus on innovative solutions that address real-world challenges. His contributions have been instrumental in advancing the field of enzymatic applications.
Collaborations
Henrik has collaborated with notable colleagues, including Martin Schulein and Grethe Norskov Rasmussen. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Henrik Fredholm's work exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations continue to influence various industries, showcasing the importance of scientific advancements.
